swissinfo.ch Roche and Novartis both sell Lucentis, a medicine for an eye disorder called wet age-related macular degeneration, dividing up the global market between them. Roche also sells a cheaper drug called Avastin, which some studies have found is just as … Italy seeks anti-trust compensation from Roche, Novartis, Pfizereuronews |
Source: Wet Macular Degeneration News From Google News